Takotsubo syndrome as a complication in a critically ill COVID-19 patient

Maurizio Bottiroli1, Daniele De Caria1, Oriana Belli2

  • 1Anesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

ESC Heart Failure
|September 5, 2020
PubMed

Insights

Takotsubo syndrome (TTS) can occur late in Coronavirus disease 2019 (COVID-19) patients, even after initial recovery. Early echocardiography is key for diagnosing and treating this cardiac complication.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Cardiac injury is a known complication of Coronavirus disease 2019 (COVID-19), associated with increased mortality.
  • The precise mechanisms and specific cardiac conditions arising during COVID-19 require further elucidation.

Observation:

  • A 76-year-old woman with COVID-19 pneumonia developed cardiogenic shock 16 days into intensive care.
  • The shock onset followed a spontaneous breathing trial via tracheostomy.
  • Bed-side echocardiography revealed apical ballooning, indicative of Takotsubo syndrome (TTS).

Findings:

  • Takotsubo syndrome (TTS) can manifest in the late stages of COVID-19.
  • The patient, initially stable with normal cardiac function, developed TTS after prolonged respiratory distress.
  • Successful treatment involved deep sedation and low-dose epinephrine.

Implications:

  • This case highlights the potential for late-onset TTS in COVID-19 patients.
  • Prompt diagnosis via bedside echocardiography is vital for managing this cardiac complication.
  • Increased awareness of late TTS can improve patient outcomes in COVID-19 critical care.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
243
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
672
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
167
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
461
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
856